๐ $INSM rockets +31% midday as BRINSUPRI drug revenue surges 49% in Q2
Insmed ($INSM) is one of today's biggest midday winners, up 31% after reporting $309.2 million in Q2 BRINSUPRI revenue โ a 49% sequential jump showing the drug is gaining serious commercial traction. The biotech's launch has blown past expectations and the stock is reflecting it. Not financial advice. Is this the start of a sustained breakout for INSM or just a one-day pop?
โก 46 buzzing
432 views
๐ 0 subscribed